Back
Synopsys Vs. Ascendis Pharma AS Industry Stock Comparison
Sell
45
SNPS
Synopsys
Last Price:
496.06
Seasonality Move:
5.94%
Sell
41
ASND
Ascendis Pharma AS
Last Price:
149.16
Seasonality Move:
6.54%
Sell
45
Synopsys (SNPS)
is a Sell
Is Synopsys a Buy, Sell or Hold?
- The current Synopsys [SNPS] share price is $502.25. The Score for SNPS is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- SNPS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Ascendis Pharma AS (ASND)
is a Sell
Is Ascendis Pharma AS a Buy, Sell or Hold?
- The current Ascendis Pharma AS [ASND] share price is $146.59. The Score for ASND is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- ASND is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SNPS Stock Price Chart
ASND Stock Price Chart
What is Ascendis Pharma AS's stock price today?
-
The Ascendis Pharma AS share price today is $146.59
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ASND is experiencing slight buying pressure.
SNPS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -13.73 | Sell |
| Relative Strength Index (14 RSI): | 47.63 | Sell |
| Chaikin Money Flow: | 77199 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (480.63 - 544.03) | Sell |
| Bollinger Bands (100): | (513.96 - 595.74) | Sell |
ASND Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.42 | Sell |
| Relative Strength Index (14 RSI): | 66.82 | Buy |
| Chaikin Money Flow: | 1073571 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
SNPS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 481.85 | Buy |
| 20-day SMA: | 504.67 | Sell |
| 50-day SMA: | 534.26 | Sell |
| 200-day SMA: | 551.73 | Sell |
| 8-day EMA: | 490.99 | Buy |
| 20-day EMA: | 500.59 | Buy |
| 50-day EMA: | 525.3 | Sell |
| 200-day EMA: | 534.01 | Sell |
ASND Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 122.89 | Buy |
| 20-day SMA: | 130.17 | Buy |
| 50-day SMA: | 132.66 | Buy |
| 200-day SMA: | 135.12 | Buy |
| 8-day EMA: | 128.84 | Buy |
| 20-day EMA: | 128.79 | Buy |
| 50-day EMA: | 131.25 | Buy |
| 200-day EMA: | 129.25 | Buy |
Synopsys Earnings Growth & SNPS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.55 per share, an increase next quarter of $0.43 per share, an increase this year of $2.05 per share, and an increase next year of $1.80 per share.
Ascendis Pharma AS Earnings Growth & ASND Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.76 per share, an increase next quarter of $1.52 per share, an increase this year of $1.66 per share, and an increase next year of $4.42 per share.
Synopsys Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ascendis Pharma AS Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||